Dr Gemma Kelly is a senior post-doctoral fellow in the Molecular Genetics of Cancer Division at the Walter and Eliza Hall Institute (WEHI). She undertook her PhD studies at the Cancer Research UK Institute at The University of Birmingham, UK where she investigated Epstein-Barr virus-associated cancers. Following the award of a Kay Kendall Leukaemia Fund Intermediate fellowship she joined the laboratory of Professor Strasser at WEHI where she continues to pursue her interests in virus-driven lymphomas and also works on understanding the role of cell death pathways in lymphoma development, with the aim of finding new targets for cancer therapy.